Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sella

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Harefuah|January 15, 1979
[Fatal pancytopenia secondary to dypirone]A J Wysenbeek, A Sella, Y Beigel, et al.
Postgraduate Medical Journal|January 1, 1980
Eosinophilic pleural effusion with high anti-DNA activity as a manifestation of systemic lupus erythematosusA J Wysenbeek, A I Pick, A Sella, et al.
Harefuah|July 29, 2000
[Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer]A Sella, D Flex, D Gafni, et al.
International Journal of Oncology|May 10, 2011
Histologic characteristics of residual renal-cell carcinoma following interferon-alpha-based therapy - correlation with clinical-parametersH Shin, J Ro, A Sella, et al.
Expert Opinion on Pharmacotherapy|December 1, 2015
Pharmacoeconomic and clinical implications of sequential therapy for metastatic renal cell carcinoma patients in Central and Eastern EuropeE Vrdoljak, L Torday, C Szczylik, et al.
Progress in Clinical and Biological Research|January 1, 1990
The impact of chemotherapy on the survival of patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, C Chong, et al.
Progress in Clinical and Biological Research|January 1, 1990
Intensive chemotherapy for metastatic nonseminomatous germ cell tumorsC J Logothetis, C Chong, F H Dexeus, et al.
The Journal of Urology|July 1, 1988
Genetic abnormalities in men with germ cell tumorsF H Dexeus, C J Logothetis, C Chong, et al.
Urology|August 30, 2000
Bladder neck involvement at radical prostatectomy: positive margins or advanced T4 disease?O Yossepowitch, D Engelstein, M Konichezky, et al.
Cancer|December 26, 2001
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapyC N Sternberg, F Calabrò, G Pizzocaro, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Harefuah|January 15, 1979
[Fatal pancytopenia secondary to dypirone]A J Wysenbeek, A Sella, Y Beigel, et al.
Postgraduate Medical Journal|January 1, 1980
Eosinophilic pleural effusion with high anti-DNA activity as a manifestation of systemic lupus erythematosusA J Wysenbeek, A I Pick, A Sella, et al.
Harefuah|July 29, 2000
[Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer]A Sella, D Flex, D Gafni, et al.
International Journal of Oncology|May 10, 2011
Histologic characteristics of residual renal-cell carcinoma following interferon-alpha-based therapy - correlation with clinical-parametersH Shin, J Ro, A Sella, et al.
Expert Opinion on Pharmacotherapy|December 1, 2015
Pharmacoeconomic and clinical implications of sequential therapy for metastatic renal cell carcinoma patients in Central and Eastern EuropeE Vrdoljak, L Torday, C Szczylik, et al.
Progress in Clinical and Biological Research|January 1, 1990
The impact of chemotherapy on the survival of patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, C Chong, et al.
Progress in Clinical and Biological Research|January 1, 1990
Intensive chemotherapy for metastatic nonseminomatous germ cell tumorsC J Logothetis, C Chong, F H Dexeus, et al.
The Journal of Urology|July 1, 1988
Genetic abnormalities in men with germ cell tumorsF H Dexeus, C J Logothetis, C Chong, et al.
Urology|August 30, 2000
Bladder neck involvement at radical prostatectomy: positive margins or advanced T4 disease?O Yossepowitch, D Engelstein, M Konichezky, et al.
Cancer|December 26, 2001
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapyC N Sternberg, F Calabrò, G Pizzocaro, et al.
Pageof 9